Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.15 - $0.54 $6,394 - $23,018
-42,627 Reduced 2.7%
1,538,130 $248,000
Q1 2022

May 13, 2022

BUY
$0.36 - $0.57 $23,281 - $36,863
64,672 Added 4.27%
1,580,757 $828,000
Q3 2021

Nov 12, 2021

BUY
$0.86 - $1.21 $20,186 - $28,402
23,473 Added 1.57%
1,516,085 $1.39 Million
Q2 2021

Aug 13, 2021

BUY
$1.04 - $1.69 $201,506 - $327,447
193,756 Added 14.92%
1,492,612 $1.78 Million
Q1 2021

May 12, 2021

BUY
$1.32 - $3.79 $448,467 - $1.29 Million
339,748 Added 35.42%
1,298,856 $2.1 Million
Q4 2020

Feb 12, 2021

SELL
$1.06 - $1.51 $14,914 - $21,245
-14,070 Reduced 1.45%
959,108 $1.19 Million
Q3 2020

Nov 13, 2020

BUY
$1.15 - $2.1 $304,308 - $555,693
264,616 Added 37.35%
973,178 $1.32 Million
Q2 2020

Aug 13, 2020

SELL
$0.48 - $1.67 $24,306 - $84,565
-50,638 Reduced 6.67%
708,562 $899,000
Q1 2020

May 14, 2020

BUY
$0.28 - $1.23 $106,528 - $467,964
380,459 Added 100.45%
759,200 $493,000
Q4 2019

Feb 13, 2020

BUY
$0.96 - $2.94 $1,974 - $6,047
2,057 Added 0.55%
378,741 $443,000
Q3 2019

Nov 12, 2019

SELL
$0.58 - $3.01 $564 - $2,928
-973 Reduced 0.26%
376,684 $941,000
Q2 2019

Aug 14, 2019

SELL
$1.47 - $3.16 $94,628 - $203,418
-64,373 Reduced 14.56%
377,657 $634,000
Q1 2019

May 14, 2019

BUY
$2.56 - $4.48 $170,106 - $297,687
66,448 Added 17.69%
442,030 $1.16 Million
Q4 2018

Feb 13, 2019

BUY
$2.98 - $6.86 $40,384 - $92,966
13,552 Added 3.74%
375,582 $1.13 Million
Q3 2018

Nov 13, 2018

BUY
$5.36 - $7.83 $158,639 - $231,744
29,597 Added 8.9%
362,030 $2.7 Million
Q2 2018

Aug 14, 2018

BUY
$5.97 - $9.58 $1.18 Million - $1.9 Million
197,963 Added 147.22%
332,433 $2.57 Million
Q4 2017

Feb 13, 2018

BUY
$3.73 - $4.6 $148,163 - $182,721
39,722 Added 41.92%
134,470 $554,000
Q2 2017

Aug 14, 2017

BUY
N/A
94,748
94,748 $304,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $3.88M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.